141 related articles for article (PubMed ID: 35928029)
1. Variation of Anxiety and Depression During a 3-Year Period as Well as Their Risk Factors and Prognostic Value in Postoperative Bladder Cancer Patients.
Guo M; Li Y; Wang W; Kang X; Chen G
Front Surg; 2022; 9():893249. PubMed ID: 35928029
[TBL] [Abstract][Full Text] [Related]
2. Anxiety and depression during 3-year follow-up period in postoperative gastrointestinal cancer patients: prevalence, vertical change, risk factors, and prognostic value.
Li J; Ma C
Ir J Med Sci; 2023 Dec; 192(6):2621-2629. PubMed ID: 36862310
[TBL] [Abstract][Full Text] [Related]
3. Prevalence, risk factors and prognostic value of anxiety and depression in cervical cancer patients underwent surgery.
Zhao H; Zhao Z; Chen C
Transl Cancer Res; 2020 Jan; 9(1):65-74. PubMed ID: 35117159
[TBL] [Abstract][Full Text] [Related]
4. A 5-year follow-up assessment of anxiety and depression in postoperative prostate cancer patients: longitudinal progression and prognostic value.
Li X; Zhang Y; Wang Y
Psychol Health Med; 2023 Feb; 28(2):529-539. PubMed ID: 36050900
[TBL] [Abstract][Full Text] [Related]
5. Postoperative anxiety and depression in surgical gastric cancer patients: their longitudinal change, risk factors, and correlation with survival.
Liu P; Wang Z
Medicine (Baltimore); 2022 Mar; 101(11):. PubMed ID: 35356898
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and correlation of anxiety and depression on the prognosis of postoperative non-small-cell lung cancer patients in North China.
Huang X; Zhang TZ; Li GH; Liu L; Xu GQ
Medicine (Baltimore); 2020 Mar; 99(11):e19087. PubMed ID: 32176035
[TBL] [Abstract][Full Text] [Related]
7. Two-scale assessment of anxiety and depression in postoperative non-small cell lung cancer patients: their prevalence, risk factors, and prognostic potency.
Deng L; Chen B
Ir J Med Sci; 2023 Dec; 192(6):2613-2619. PubMed ID: 36826710
[TBL] [Abstract][Full Text] [Related]
8. Prevalence, risk factors and prognostic role of anxiety and depression in surgical gastric cancer patients.
Han L
Transl Cancer Res; 2020 Mar; 9(3):1371-1383. PubMed ID: 35117485
[TBL] [Abstract][Full Text] [Related]
9. Prevalence, risk factors and prognostic value of anxiety and depression in recurrent glioma patients.
Liu X; Zhan G
Psychol Health Med; 2023; 28(9):2474-2485. PubMed ID: 37271963
[TBL] [Abstract][Full Text] [Related]
10. Active disease is independently associated with more severe anxiety rather than depressive symptoms in patients with systemic lupus erythematosus.
Tay SH; Cheung PP; Mak A
Lupus; 2015 Nov; 24(13):1392-9. PubMed ID: 26085594
[TBL] [Abstract][Full Text] [Related]
11. The longitudinal changes of anxiety and depression, their related risk factors and prognostic value in colorectal cancer survivors: a 36-month follow-up study.
Zhou L; Sun H
Clin Res Hepatol Gastroenterol; 2021 Jul; 45(4):101511. PubMed ID: 33713979
[TBL] [Abstract][Full Text] [Related]
12. Screening for depression and anxiety in childhood neurogenic bladder dysfunction.
Kabra AT; Feustel PJ; Kogan BA
J Pediatr Urol; 2015 Apr; 11(2):75.e1-7. PubMed ID: 25824880
[TBL] [Abstract][Full Text] [Related]
13. Anxiety and depression in patients with moderate-to-severe psoriasis and comparison of change from baseline after treatment with guselkumab vs. adalimumab: results from the Phase 3 VOYAGE 2 study.
Gordon KB; Armstrong AW; Han C; Foley P; Song M; Wasfi Y; You Y; Shen YK; Reich K
J Eur Acad Dermatol Venereol; 2018 Nov; 32(11):1940-1949. PubMed ID: 29706008
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Hospital Anxiety and Depression Scale (HADS) and Zung Self-Rating Anxiety/Depression Scale (SAS/SDS) in Evaluating Anxiety and Depression in Patients with Psoriatic Arthritis.
Yue T; Li Q; Wang R; Liu Z; Guo M; Bai F; Zhang Z; Wang W; Cheng Y; Wang H
Dermatology; 2020; 236(2):170-178. PubMed ID: 31434087
[TBL] [Abstract][Full Text] [Related]
15. Anxiety and depression in glioma patients: prevalence, risk factors, and their correlation with survival.
Hao A; Huang J; Xu X
Ir J Med Sci; 2021 Aug; 190(3):1155-1164. PubMed ID: 33140294
[TBL] [Abstract][Full Text] [Related]
16. Intensive patient's care program reduces anxiety and depression as well as improves overall survival in
Bao H; Chen Y; Li M; Pan L; Zheng X
Transl Cancer Res; 2019 Feb; 8(1):212-227. PubMed ID: 35116750
[TBL] [Abstract][Full Text] [Related]
17. Patients' self-report anxiety, depression and quality of life and their predictive factors in muscle invasive bladder cancer patients receiving adjuvant chemotherapy.
Zhang Y; Wang Y; Song B; Li H
Psychol Health Med; 2020 Feb; 25(2):190-200. PubMed ID: 31698952
[TBL] [Abstract][Full Text] [Related]
18. Anxiety and depression in rheumatoid arthritis patients: prevalence, risk factors and consistency between the Hospital Anxiety and Depression Scale and Zung's Self-rating Anxiety Scale/Depression Scale.
Cheng L; Gao W; Xu Y; Yu Z; Wang W; Zhou J; Zang Y
Rheumatol Adv Pract; 2023; 7(3):rkad100. PubMed ID: 38033365
[TBL] [Abstract][Full Text] [Related]
19. Anxiety faintly and depression remarkably correlate with recurrence in acute ischemic stroke patients: A study with 3-year longitude evaluation and follow-up.
Luan S; Wu X; Yin S
Medicine (Baltimore); 2022 Jan; 101(3):e28521. PubMed ID: 35060506
[TBL] [Abstract][Full Text] [Related]
20. Quantitative analyses of factors related to anxiety and depression in patients with retinitis pigmentosa.
Sainohira M; Yamashita T; Terasaki H; Sonoda S; Miyata K; Murakami Y; Ikeda Y; Morimoto T; Endo T; Fujikado T; Kamo J; Sakamoto T
PLoS One; 2018; 13(4):e0195983. PubMed ID: 29684094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
